(Q38056532)

27 August 2017

title

Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

27 August 2017

0 references

0 references

1 reference

William MacNee

1

0 references

language of work or name

English

0 references

publication date

30 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

45

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

291-300

1 reference

COPD: a multifactorial systemic disease

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Chronic obstructive pulmonary disease: a view from the NHLBI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Mortality in COPD: Role of comorbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

The risk of osteoporosis in Caucasian men and women with obstructive airways disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Relationship between gastroesophageal reflux disease and COPD in UK primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

The prevalence of quadriceps weakness in COPD and the relationship with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Patterns of comorbidities in newly diagnosed COPD and asthma in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Treatment of chronic obstructive pulmonary disease and its comorbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Systemic effects of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

The interactions between cigarette smoking and reduced lung function on systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Cardiovascular risk in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Systemic manifestations and comorbidities of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Airway and systemic inflammation and decline in lung function in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Biomarkers in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Biomarkers in COPD: time for a deep breath

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Biomarkers in the assessment and management of airways diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Profiling serum biomarkers in patients with COPD: associations with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Raised CRP levels mark metabolic and functional impairment in advanced COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Impaired lung function and serum leptin in men and women with normal body weight: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Systemic inflammation and mortality in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

The role of oxidative stress in the pathogenesis of COPD: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Strenuous resistive breathing induces plasma cytokines: role of antioxidants and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Markers of disease severity in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Desmosine as a biomarker of elastin degradation in COPD: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

The effect of tiotropium therapy on markers of elastin degradation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

COPD exacerbations: defining their cause and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Nutritional aspects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Possible mechanisms underlying the development of cachexia in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Previous lung diseases and lung cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Characterisation of COPD heterogeneity in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Systemic Inflammation and COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Systemic Inflammation, COPD, and Pulmonary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Increased platelet activation in patients with stable and acute exacerbation of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

Systemic oxidative stress in asthma, COPD, and smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

From COPD to chronic systemic inflammatory syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.732703

10.3109/07853890.2012.732703

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference